Financial Times - July 4
July 4 (Reuters) -The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.
Headlines
- EQT strikes 2.2 bln STG deal for Irish video gaming group Keywords Studios
- Hawksmoor restaurant chain up for sale
- Germany vetoes sale of sensitive turbine unit to Chinese group
- GSK signs 1.4 bln euros mRNA vaccine deal with troubled biotech CureVac
Overview
- A consortium led by Swedish private equity group EQT EQTAB.ST has agreed to acquire Irish video games company Keywords Studios in a 2.2 billion pounds ($2.80 billion) deal.
- London-based Hawksmoor has been put up for sale in a deal that could value the restaurant chain at about 100 million pounds ($127.42 million) as it seeks to grow its international footprint.
- Germany vetoes sale of a turbine unit of Volkswagen VOWG_p.DE unit MAN Energy Solutions to a China State Shipbuilding Corporation subsidiary for protecting "technologies relevant to public security".
- British drugmaker GSK GSK.L has reached a licensing agreement with mRNA vaccine developer CureVac worth up to 1.4 billion euros ($1.51 billion) to develop its vaccines for flu, Covid-19 and avian flu.
($1 = 0.7848 pounds)
($1 = 0.9270 euros)
(Compiled by Bengaluru Newsroom)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
